AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54

Authors: Drake, WM Parkinson, C Besser, GM Trainer, PJ
Citation: Wm. Drake et al., Clinical use a of growth hormone receptor antagonist in the treatment of acromegaly, TRENDS ENDO, 12(9), 2001, pp. 408-413

Authors: Drake, WM Parkinson, C Akker, SA Monson, JP Besser, GM Trainer, PJ
Citation: Wm. Drake et al., Successful treatment of resistant acromegaly with a growth hormone receptor antagonist, EUR J ENDOC, 145(4), 2001, pp. 451-456

Authors: Savage, MO Lienhardt, A Lebrethon, MC Johnston, LB Huebner, A Grossman, AB Afshar, F Plowman, PN Besser, GM
Citation: Mo. Savage et al., Cushing's disease in childhood: presentation, investigation, treatment andlong-term outcome, HORMONE RES, 55, 2001, pp. 24-30

Authors: Monson, JP Coyte, D Kaltsas, G Jenkins, PJ Chew, SL Grossman, AB Besser, GM
Citation: Jp. Monson et al., Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply, CLIN ENDOCR, 55(5), 2001, pp. 696-697

Authors: Siddiqi, A Foley, RR Britton, KE Sibtain, A Plowman, PN Grossman, AB Monson, JP Besser, GM
Citation: A. Siddiqi et al., The role of I-123-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to I-131-scanning: avoidance of negative therapeutic uptake due to stunning, CLIN ENDOCR, 55(4), 2001, pp. 515-521

Authors: Mukherjee, JJ Kaltsas, GA Islam, N Plowman, PN Foley, R Hikmat, J Britton, KE Jenkins, PJ Chew, SL Monson, JP Besser, GM Grossman, AB
Citation: Jj. Mukherjee et al., Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with I-131-meta-iodobenzylguanidine (I-131-mIBG), CLIN ENDOCR, 55(1), 2001, pp. 47-60

Authors: Korbonits, M Chitnis, MM Gueorguiev, M Norman, D Rosenfelder, N Suliman, M Jones, TH Noonan, K Fabbri, A Besser, GM Burrin, JM Grossman, AB
Citation: M. Korbonits et al., The release of leptin and its effect on hormone release from human pituitary adenomas, CLIN ENDOCR, 54(6), 2001, pp. 781-789

Authors: Miraki-Moud, F Jenkins, PJ Fairclough, PD Jordan, S Bustin, SA Jones, AM Lowe, DG Monson, JP Grossman, AB Besser, GM Camacho-Hubner, C
Citation: F. Miraki-moud et al., Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly, CLIN ENDOCR, 54(4), 2001, pp. 499-508

Authors: Drake, WM Rodriguez-Arnao, J Weaver, JU James, IT Coyte, D Spector, TD Besser, GM Monson, JP
Citation: Wm. Drake et al., The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitaryadults: a 5-year study, CLIN ENDOCR, 54(4), 2001, pp. 525-532

Authors: van der Lely, AJ Hutson, RK Trainer, PJ Besser, GM Barkan, AL Katznelson, L Klibanski, A Herman-Bonert, V Melmed, S Vance, ML Freda, PU Stewart, PM Friend, KE Clemmons, DR Johannsson, G Stavrou, S Cook, DM Phillips, LS Strasburger, CJ Hacker, S Zib, KA Davis, RJ Scarlett, JA Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759

Authors: Monson, JP Besser, GM
Citation: Jp. Monson et Gm. Besser, Premature mortality and hypopituitarism, LANCET, 357(9272), 2001, pp. 1972-1973

Authors: Trainer, PJ Drake, WM Perry, LA Taylor, NF Besser, GM Monson, JP
Citation: Pj. Trainer et al., Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly, J CLIN END, 86(7), 2001, pp. 2989-2992

Authors: Aylwin, SJB Welch, JP Davey, CL Geddes, JF Wood, DF Besser, GM Grossman, AB Monson, JP Burrin, JM
Citation: Sjb. Aylwin et al., The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas, J CLIN END, 86(6), 2001, pp. 2476-2483

Authors: Kaltsas, GA Isidori, AM Florakis, D Trainer, PJ Camacho-Hubner, C Afshar, F Sabin, I Jenkins, JP Chew, SL Monson, JP Besser, GM Grossman, AB
Citation: Ga. Kaltsas et al., Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity, J CLIN END, 86(4), 2001, pp. 1645-1652

Authors: Kaltsas, G Korbonits, M Heintz, E Mukherjee, JJ Jenkins, PJ Chew, SL Reznek, R Monson, JP Besser, GM Foley, R Britton, KE Grossman, AB
Citation: G. Kaltsas et al., Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors, J CLIN END, 86(2), 2001, pp. 895-902

Authors: Frajese, G Drake, WM Loureiro, RA Evanson, J Coyte, D Wood, DF Grossman, AB Besser, GM Monson, JP
Citation: G. Frajese et al., Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy, J CLIN END, 86(11), 2001, pp. 5172-5175

Authors: Veysey, MJ Malcolm, P Mallet, AI Jenkins, PJ Besser, GM Murphy, GM Dowling, RH
Citation: Mj. Veysey et al., Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial, GUT, 49(6), 2001, pp. 828-834

Authors: Veysey, MJ Thomas, LA Mallet, AI Jenkins, PJ Besser, GM Murphy, GM Dowling, RH
Citation: Mj. Veysey et al., Colonic transit influences deoxycholic acid kinetics, GASTROENTY, 121(4), 2001, pp. 812-822

Authors: Owen, NJ Sohaib, SAA Peppercorn, PD Monson, JP Grossman, AB Besser, GM Reznek, RH
Citation: Nj. Owen et al., MRI of pancreatic neuroendocrine tumours, BR J RADIOL, 74(886), 2001, pp. 968-973

Authors: Pollak, M Besser, GM Cohen, P Rosenfeld, RG
Citation: M. Pollak et al., First International Workshop on Growth Hormone, Insulin-like Growth Factors and Neoplasia, GROWTH H I, 10, 2000, pp. S1-S3

Authors: Jenkins, PJ Akker, S Chew, SL Besser, GM Monson, JP Grossman, AB
Citation: Pj. Jenkins et al., Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration, CLIN ENDOCR, 53(6), 2000, pp. 719-724

Authors: Florakis, D Hung, V Kaltsas, G Coyte, D Jenkins, PJ Chew, SL Grossman, AB Besser, GM Monson, JP
Citation: D. Florakis et al., Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two yearstudy, CLIN ENDOCR, 53(4), 2000, pp. 453-459

Authors: Kaltsas, GA Korbonits, M Isidori, AM Webb, JAW Trainer, PJ Monson, JP Besser, GM Grossman, AB
Citation: Ga. Kaltsas et al., How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?, CLIN ENDOCR, 53(4), 2000, pp. 493-500

Authors: Johnston, LB Chew, SL Trainer, PJ Reznek, R Grossman, AB Besser, GM Monson, JP Savage, MO
Citation: Lb. Johnston et al., Screening children at risk of developing inherited endocrine neoplasia syndromes, CLIN ENDOCR, 52(2), 2000, pp. 127-136

Authors: Geddes, JF Jansen, GH Robinson, SFD Gomori, E Holton, JL Monson, JP Besser, GM Revesz, T
Citation: Jf. Geddes et al., 'Gangliocytomas' of the pituitary - A heterogeneous group of lesions with differing histogenesis, AM J SURG P, 24(4), 2000, pp. 607-613
Risultati: 1-25 | 26-50 | 51-54